Introduction {#section1-1010539520928180}
============

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak has become the main concern for public health emergency particularly for the countries in the northern hemisphere.^[@bibr1-1010539520928180]^ After starting in Chinese city of Wuhan on December 31, 2019, scientific research has focused on whether the disease will remain limited in a particular area with a small number of patients as were in SARS-CoV and MERS-CoV (Middle East respiratory syndrome coronavirus) outbreaks.

Artificial intelligence tools based on machine learning and mathematical models are being used to estimate the nature of the spread across each country, and to detect the potential amplifiers hampering the effects of the epidemic.^[@bibr2-1010539520928180]^

This study aims to develop a model by means of the data from China, Italy, South Korea, and Turkey, by using cumulative cases and cumulative death toll starting from the diagnosis of the first case in each country.

Materials and Methods {#section2-1010539520928180}
=====================

Data Analysis {#section3-1010539520928180}
-------------

We used data of three countries (China, Italy, and South Korea) with a total number of cases exceeding 9000 as of March 26, 2020, as well as in Turkey within a 2-week period after the first case(s) of COVID-19 (coronavirus disease 2019).

### China (Wuhan, Hubei) {#section4-1010539520928180}

The infection first emerged in Wuhan, the capital city of Hubei province, and then spread to the entire country during a very short time. However, the spread has been gradually brought under control through strict measures. The total number of cases till March 25, 2020, was 81 218. The main purpose of modelling of the outbreak in Hubei is to observe the natural course of the outbreak and its long-term consequences. Thus, insight for other countries, including Turkey, which is on the verge of the outbreak, can be obtained.

### Italy {#section5-1010539520928180}

The first positive case was diagnosed on January 31, 2020. Data have been modeled for Italy because of the increasing number of cases and high mortality.^[@bibr3-1010539520928180]^

### South Korea {#section6-1010539520928180}

The first positive case was announced on January 20, 2020. Data have been modeled for South Korea because it is currently one of the countries that manages the outbreak very well.

### Turkey {#section7-1010539520928180}

The first positive case was reported on March 10, 2020. Since the outbreak has just emerged in Turkey, data have also been modeled for Turkey as well.

Indicators {#section8-1010539520928180}
----------

Indicators utilized for modelling are the cumulative case and cumulative death toll for each day. For the comparison of countries, cumulative cases, cumulative death toll, and new cases were standardized by population size. The data were obtained from the World Health Organization and the Worldometer.^[@bibr3-1010539520928180][@bibr4-1010539520928180]-[@bibr5-1010539520928180]^

Different nonlinear models were tested, and the results of the most suitable model are given.

Model Validation for Suitability {#section9-1010539520928180}
--------------------------------

For external validation, we examined whether the model types in each country are the same. In addition, the consistency between 16-day predictions obtained in this study and 10-day predictions in the study by Ankarali et al were accepted as internal validation.^[@bibr6-1010539520928180]^

Statistical Analysis {#section10-1010539520928180}
--------------------

Exponential, quadratic, power, cubic, logistic, and growth curves were applied to the logarithmic values. In choosing the best predictive model, Akaike information criterion, prediction accuracy measure (R^2^ %), and mean squared error were used. Among the models, the most successful estimation was obtained from the cubic model. The appropriate mathematical model is as described below.

### Cubic Model {#section11-1010539520928180}

The model that is defined as follows:

$${Ln}\left( Y \right)\  = b0\  + \ (b1*t)\  + \ (b2*t**2)\  + \ (b3*t**3)$$

where *Y* are the cumulative case and cumulative death, *b* is the regression coefficient, and *t* is the time (day).

The criteria for performance and model coefficients of the selected model were given. GraphPad Prism (Trial Version 4.0a), Stata (Version 14), and SPSS (Version 23) programs were used.

Results {#section12-1010539520928180}
=======

[Table 1](#table1-1010539520928180){ref-type="table"} and [Figure 1](#fig1-1010539520928180){ref-type="fig"} show the results of the model of the countries.

###### 

Results of Prediction and Forecasting for Turkey.

![](10.1177_1010539520928180-table1)

  Prediction date   Observed      Predicted                                                                   
  ----------------- ------------- ------------------------ --------- ------------------ -------- ------ ----- -----
  March 25, 2020    2433          59                       29 659    23 212             36 107   594    543   644
  March 25, 2020    3629          75                       39 381    32 666             46 096   747    695   800
  March 27, 2020    5698          92                       51 057    43 521             58 594   924    865   983
  Forecast                                                                                                    
  Forecast date     Total cases   95% CI for total cases   Death     95% CI for death                         
  March 28, 2020    64 866        55 661                   74 071    1126               1054     1198         
  March 29, 2020    80 984        69 107                   92 861    1354               1261     1447         
  March 30, 2020    99 587        83 993                   115 181   1611               1489     1733         

Abbreviation: CI, confidence interval for predictions/forecasting.

![Observed versus predicted values according to the model in each country.](10.1177_1010539520928180-fig1){#fig1-1010539520928180}

Determination coefficient of the models was calculated to be around 99%. When the results are examined, the outbreak is expected to end in the second week of April in China and in the beginning of April in South Korea. However, no significant decrease is observed in Italy. Since the evaluation period is too short, further prediction of the outbreak process cannot be made for Turkey.

When the four countries have been compared in terms of their total case prevalence, the results were similar for the first 15 days. However, differences have emerged after the second week in China, Italy, and South Korea. The number of cases per population was lowest in China, in the 22^nd^ day of the outbreak.

On the 22^nd^ day, the number of cases was lower in Italy than in South Korea. The breaking point in South Korea was around the 20^th^ day, and in China after the 25^th^ day. However, the breaking point for Italy and Turkey has not yet occurred.

The total death prevalence per 1 million people in China and South Korea for the first 15 days were similar. However, the course of the outbreak remained unclear in Turkey.

The number of new cases per 1 million people was lowest in China generally. In South Korea, the number of new cases observed was higher than in China, especially between the seventh and 20^th^ days. This prevalence was highest in Italy and had a very different course than the other three countries.

Although the highest number of new cases per 1 million people in China was 9.8 on February 28, 2020, it gradually decreased to 0.54 per 1 million people on March 25, 2020, which was similar to that of the new cases on January 20, 2020. Considering the date December 31, 2019, as the start of the outbreak, the duration to the culmination of new cases was 59 days (December 31, 2019, to February 28, 2020).

The highest number of new cases per 1 million people in Italy was 108.4 on March 21, 2020. However, it ended up with 79.2 per 1 million people on March 25, 2020. Considering the date February 15, 2020, as the start of the outbreak in Italy, the duration to the culmination of new cases was 37 days (February 15, 2020, to March 21, 2020).

While the highest number of new cases per 1 million people in South Korea was 16.6 on March 5, 2020, it ended up with 1.25 per 1 million people on March 24, 2020, which was similar to that of the cases on February 18 to 19, 2020. Considering February 15, 2020, as the start of the outbreak, the duration to the culmination of new cases was 15 days (February 15, 2020, to March 5, 2020).

Although the number of new cases increased day by day in Turkey, the rate started to decrease in the past 2 days. On March 27, 2020, 18 days after the first diagnosis appeared in Turkey, the number of new cases was 24.6 per 1 million people. Although this number was lower than total cases seen 18 days after the first diagnosis appeared in South Korea, it was higher than total cases seen 18 days after the first diagnosis appeared in China. China has reached this number in just one day and remained below in the remaining days.

Conclusion {#section13-1010539520928180}
==========

The prediction of the spread of the outbreak process is of great importance for future measures to be taken. In this study, we show that the cubic curve modeling can be successfully adapted to the four countries' epidemic data, which include the total number of confirmed cases and death toll. China and South Korea, as the primary centers of the epidemic, provide significant input on how epidemic dynamics can be altered through preventative measures implied. In contrast, the experience in Italy, where the outbreak has still not been brought under control, will remain a significant observation for future studies. On the other hand, a breakpoint for Turkey, which is currently at the initial phase of the epidemic, could not be determined. However, since the selected model offers reliable results, the model coefficients will be re-estimated at 5-day intervals by adding the daily data and forecasting will be revised and recalculated for the next 5 days.
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